Duramatrix
Device Neuro
PDI 00813954020181
General payments
$71,192
Research payments
$2,875
Through program year 2025, $71,192 in general payments and $2,875 in research payments were reported against Duramatrix (Neuro).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $16,543 | 235 |
| 2024 | General | $22,688 | 265 |
| 2024 | Research | $2,875 | 1 |
| 2023 | General | $12,175 | 188 |
| 2022 | General | $8,813 | 152 |
| 2021 | General | $10,973 | 115 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
955 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.